Search

everythinglearnresearchcommunity

for

Search:↓

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Apremilast may be a promising long-term treatment for hidradenitis suppurativa.

Thrice-weekly dutasteride improved hair density and thickness more than twice-weekly, but not hair count compared to daily finasteride.

A reliable method was created to measure dutasteride and related molecules in capsules.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Denosumab may cause alopecia areata.

The cream effectively treats scalp psoriasis, improving symptoms and quality of life, with high patient satisfaction.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Two people lost hair unexpectedly after getting a common hair loss treatment with a drug called Dutasteride.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

Anti-Desmocollin 3 antibodies can cause pemphigus-like symptoms in mice.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Adrenomedullin 2 stops cell growth and causes cell death in human hair follicles.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Triamcinolone acetonide therapy for hair loss may cause a skin condition called linear lichen planus.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.